InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.00
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,140.87
(
0.08%
)
Post# of 5735
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lefty18

Send PM Follow Ignore
Followers 43
Posts 3041
Boards Moderated 1
Alias Born 08/09/2006

lefty18

Re: None

Wednesday, 03/30/2011 2:27:06 PM

Wednesday, March 30, 2011 2:27:06 PM

Post# of 5735
What's curious to me is that Dr. Bauer states that the objective of the study was to determine if Cypath could differentiate between the high risk and the the cancer group.

Wouldn't it be more useful to determine if Cypath could differentiate between those with high risk vs. those that are at low risk? I'll try to call and clarify this.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up